E Fund Management Co., Ltd.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1842296
GUANGZHOU, F4
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,216,219
-$511,769 QoQ
Shares Held
5,158
+6.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#445
of 1,322 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. REGN ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,455 | $5,690,042 | |
| 2 | ERAS |
Erasca, Inc.
|
265,381 | $4,861,779 | |
| 3 | CELC |
Celcuity Inc.
|
45,895 | $4,801,534 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,774 | $4,730,068 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
109,328 | $3,798,054 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,158 | $3,216,219 | |
| 7 | LEGN |
Legend Biotech Corp
|
109,327 | $3,157,363 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,073 | $1,828,155 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,216,219 | 5,158 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $3,727,988 | 4,825 | Shares | Defined | 2026-04-13 | |
| 2025-06-30 | $2,797,725 | 5,329 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,115,337 | 4,912 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,278,031 | 3,198 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $2,385,263 | 2,269 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,458,359 | 2,339 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,629,495 | 1,693 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,590,583 | 1,811 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,508,485 | 1,833 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,235,888 | 1,720 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,483,114 | 1,805 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,394,640 | 1,933 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,470,048 | 2,134 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,290,436 | 2,183 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,262,743 | 1,808 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,052,743 | 1,667 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,005,809 | 1,662 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $821,371 | 1,736 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||